TrialCancer medicine2023

Combined all-trans retinoic acid with low-dose apatinib in treatment of recurrent/metastatic head and neck adenoid cystic carcinoma: A single-center, secondary analysis of a phase II study.

Lulu Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.